Zobrazeno 1 - 10
of 541
pro vyhledávání: '"Martin, Rudwaleit"'
Autor:
Xenofon Baraliakos, Martin Rudwaleit, Pedro M Machado, Bengt Hoepken, Lars Bauer, Rachel Tham, Thomas Kumke, Mindy Kim
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Background A consensus definition for active sacroiliitis by MRI, mentioned in the Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis (axSpA), was published in 2009 and included a qualitat
Externí odkaz:
https://doaj.org/article/126007b01be948edb4249597ec2dda05
Autor:
Filip van den Bosch, Martin Rudwaleit, Helena Marzo-Ortega, Natasha de Peyrecave, Victoria Navarro-Compán, Lars Bauer, Rachel Tham, Thomas Kumke, Mindy Kim
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Introduction This post hoc analysis evaluated the relationship between objective measures of inflammation and clinical outcomes following 12 weeks of certolizumab pegol (CZP) treatment in patients with active axial spondyloarthritis (axSpA).Methods W
Externí odkaz:
https://doaj.org/article/fdb0162a072d4d89a88c1d9b1c6ae796
Autor:
Annelies Boonen, Atul Deodhar, Martin Rudwaleit, Lianne S Gensler, Karl Gaffney, Maureen Dubreuil, Victoria Navarro-Compán, Vanessa Taieb, Carmen Fleurinck, Ute Massow, Thomas Vaux, Michael F Mørup, Christine de la Loge
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objective To assess the impact of bimekizumab on physical functioning, sleep, work productivity and overall health-related quality of life (HRQoL) in patients with non-radiographic (nr-) and radiographic (r-) axial spondyloarthritis (axSpA) in the ph
Externí odkaz:
https://doaj.org/article/6e49044faaf046c4839ca01e2aea5e2a
Autor:
Atul Deodhar, Martin Rudwaleit, Bengt Hoepken, Lars Bauer, Lianne Gensler, Walter Maksymowych, Thomas Kumke, Mindy Kim, Simone Emanuele Auteri
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objective There is a paucity of data on long-term clinical responses in patients with non-radiographic axial spondyloarthritis (nr-axSpA) based on their baseline objective signs of inflammation such as MRI or C-reactive protein (CRP) levels. This stu
Externí odkaz:
https://doaj.org/article/255ce8dc541946c78286251d8e855a46
Autor:
Sofia Ramiro, Atul Deodhar, Philip J Mease, Martin Rudwaleit, Jonathan Kay, Marina Magrey, Victoria Navarro-Compán, Vanessa Taieb, Carmen Fleurinck, Ute Massow, Michael F Mørup, Christine de la Loge
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objective To assess how achievement of increasingly stringent clinical response criteria and disease activity states at week 52 translate into changes in core domains in patients with non-radiographic (nr-) and radiographic (r-) axial spondyloarthrit
Externí odkaz:
https://doaj.org/article/b0bf5a183aca4f3db52fc23fd3c2cd26
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rebecca M. Seifert, Michael Rauch, Randolf Klingebiel, Lennart-Maximilian Boese, Isabell Greeve, Martin Rudwaleit, Wolf-Rüdiger Schäbitz
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundCerebral amyloid angiopathy-related inflammation (CAA-ri) defines a subacute autoimmune encephalopathy, which is presumably caused by increased CSF concentrations of anti-Aβ autoantibodies. This autoinflammatory reaction is temporally and
Externí odkaz:
https://doaj.org/article/3d514b568ca44962a8ed83bb82bb9842
Autor:
Annelies Boonen, Martin Rudwaleit, Brittany Humphries, Vanessa Taieb, Michael F Mørup, Noor-E Zannat, Damon Willems
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Background Axial spondyloarthritis (axSpA) can limit work participation. Our objective was to characterise productivity in patients with axSpA, including changes after 12–16 weeks of treatment with biological and targeted synthetic disease-modifyin
Externí odkaz:
https://doaj.org/article/07a0328cd399436b90b15aef8c00a208
Autor:
Philip C. Robinson, Walter P. Maksymowych, Lianne S. Gensler, Stephen Hall, Martin Rudwaleit, Bengt Hoepken, Lars Bauer, Thomas Kumke, Mindy Kim, Natasha dePeyrecave, Atul Deodhar
Publikováno v:
ACR Open Rheumatology, Vol 4, Iss 9, Pp 794-801 (2022)
Objective Tumor necrosis factor inhibitors (TNFi) are an effective treatment for non‐radiographic axial spondyloarthritis (nr‐axSpA). To be eligible, however, many authorities require patients with nr‐axSpA to show active sacroiliitis on magnet
Externí odkaz:
https://doaj.org/article/07fdd47c79c04d2ab7b1f38ef75b414b
Autor:
Martin Rudwaleit, Pedro M. Machado, Vanessa Taieb, Natasha de Peyrecave, Bengt Hoepken, Lianne S. Gensler
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 15 (2023)
Background: Patients with active axial spondyloarthritis (axSpA) exhibit more absences and lower levels of productivity in the workplace and household than the general population, which can improve upon treatment. Objectives: The objective of this st
Externí odkaz:
https://doaj.org/article/6a013dbb17ac4e61b73a99928eecf072